US Patent Issued to ImmunityBio on Sept. 9 for "Neoepitope vaccine delivery vehicle and methods of making the same" (California Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,135, issued on Sept. 9, was assigned to ImmunityBio Inc. (Culver City, Calif.).

"Neoepitope vaccine delivery vehicle and methods of making the same" was invented by Philip T. Liu (Culver City, Calif.), Clifford Anders Olson (Culver City, Calif.), Wade Nichols Richardson (Culver City, Calif.) and Wendy Higashide (Culver City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are mannan nanogels as a novel vaccine delivery platform as well as a novel method of making a self-assembling mannan nanogel for in vivo delivery of therapeutic agents."

The patent was filed on Dec. 6, 2022, under Application No. 18/062,416.

*For further ...